Intelligence with control, accountability and traceability.
Designed for regulated clinical research—where AI assistance should accelerate work without bypassing accountable review, controlled configuration or attributable release.
AI output stays reviewable until people decide.
Protocol interpretations, study-design proposals, summaries and recommended actions can be prepared by AI, but controlled study setup is based on authorized decisions and approved study intelligence.
Propose → Approve → Compile → Release
AI-generated design is not automatically treated as executable configuration. Approved study intelligence passes through validation and module-specific compilation before controlled release.
Know where every configuration came from.
GarudaSphere is designed to preserve the relationship between protocol source, interpreted study facts, human decisions and deployed configuration.
Source
Protocol section, clause or controlled input document.
Interpretation
Structured study fact or AI-generated design proposal.
Decision
Authorized review, correction and approval.
Compilation
Rule, compiler and version used to build configuration.
Execution
Resulting form, edit check, workflow, document plan or application setting.
Support validated use in regulated clinical research.
GarudaSphere's architecture is intended to support controlled deployment and workflows aligned with applicable clinical-research and electronic-record expectations.
21 CFR Part 11
Design support for controlled electronic records, signatures, access and auditability.
ICH-GCP
Workflow design centered on participant protection, data reliability and accountable trial conduct.
ALCOA+
Architecture intended to support attributable, legible, contemporaneous, original and accurate records.
Controlled Lifecycle
Support for requirements, testing, release control, traceability and change management.
Trust is part of the product architecture.
Talk to us about human governance, validation strategy, controlled compilation and the deployment model for GarudaSphere.